Cationic Host Defence Peptides: Potential as Antiviral Therapeutics
There is a pressing need to develop new antiviral treatments; of the 60 drugs currently available, half are aimed at HIV-1 and the remainder target only a further six viruses. This demand has led to the emergence of possible peptide therapies, with 15 currently in clinical trials. Advancements in un...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Springer International Publishing
2013
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775153/ |